This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1995-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1999
Title: Jorg Petersen Von Gehr: Innovator in Pharmaceutical Chemistry
Introduction
Jorg Petersen Von Gehr is a notable inventor based in Bochum, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing new compounds that have potential therapeutic applications.
Latest Patents
Among his latest patents are "Substituted Triols" and "Substituted Pyridines." The latter patent describes the preparation of new substituted pyridines by reducing suitably substituted pyridine derivatives. These new compounds are particularly promising as active ingredients in pharmaceuticals, especially for the treatment of hyperlipoproteinaemia.
Career Highlights
Jorg Petersen Von Gehr is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to explore and develop innovative solutions that address critical health issues.
Collaborations
Throughout his career, Jorg has collaborated with esteemed colleagues such as Rolf Angerbauer and Peter Fey. These collaborations have further enriched his research and contributed to the advancement of pharmaceutical sciences.
Conclusion
Jorg Petersen Von Gehr's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile